Zhonghong Pulin Medical Products (300981.SZ): Subsidiary Kelun Medical Devices is proposed as a selected candidate in a centralized volume-based procurement project.
Zhonghong Pulin Medical Products (300981.SZ) announced that its controlled subsidiary Jiangxi Kelun Medical Device Manufacturing Co., Ltd. ("Kelun Medical Devices") recently participated in the bidding for the Fujian Province-wide alliance centralized volume-based procurement of single-use human venous blood collection needles. According to the announcement on the Fujian Province-wide alliance centralized volume-based procurement of single-use human venous blood collection needles, some products of Kelun Medical Devices are proposed as selected candidates in the above centralized volume-based procurement project. The products proposed for selection this time include: "soft-connection venous blood collection needles (general type)" and "hard-connection venous blood collection needles."
Zhonghong Pulin Medical Products (300981.SZ) announced that its controlled subsidiary Jiangxi Kelun Medical Device Manufacturing Co., Ltd. ("Kelun Medical Devices") recently participated in the bidding for the Fujian Province-wide alliance centralized volume-based procurement of single-use human venous blood collection needles. According to the announcement on the Fujian Province-wide alliance centralized volume-based procurement of single-use human venous blood collection needles, some products of Kelun Medical Devices are proposed as selected candidates in the aforementioned centralized volume-based procurement project. The products proposed for selection this time include: "soft-connection venous blood collection needles (standard type)" and "hard-connection venous blood collection needles."
Related Articles

DAWNRAYS PHARMA (02348) repurchased 212,000 shares on November 4 for HK$195,600.

Midea Group Co., Ltd (00300) repurchased 569,100 A shares on November 4 for RMB50.0087 million.

HK&S HOTELS (00045): Peninsula Hotels' Greater China RevPAR for Q3 2026 was HK$2,912
DAWNRAYS PHARMA (02348) repurchased 212,000 shares on November 4 for HK$195,600.

Midea Group Co., Ltd (00300) repurchased 569,100 A shares on November 4 for RMB50.0087 million.

HK&S HOTELS (00045): Peninsula Hotels' Greater China RevPAR for Q3 2026 was HK$2,912






